RxSight, Inc.

RxSight, Inc. (RXST) Stock Overview

Explore RxSight, Inc.’s financial performance, market position, analyst ratings, and future outlook.

RXSTNASDAQ
HealthcareMedical - Devices
$5.55
$0.02(0.36%)
U.S. Market opens in 5h 47m

RxSight, Inc. (RXST)

Meyka AI Score

Z

Key Financials

Market Cap229.8M
P/E Ratio-4.88
EPS (TTM)$-0.72
ROE-0.17%
Fundamental Analysis

AI Price Forecasts

1 Month$5.24
3 Months$11.96
1 Year Target$0.00

RXST Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of RxSight, Inc. (RXST) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 55.75, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -4.88 and a market capitalization of 229.8M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.36%
5-Day Change
9.25%
1-Month Change
20.92%
3-Month Change
-27.07%
6-Month Change
-43.43%
Year-to-Date (YTD) Change
-46.74%
1-Year Change
-24.80%
3-Year Change
-83.06%
5-Year Change
-65.31%
All-Time (Max) Change
-65.31%

Contact Information

949 521 7830
100 Columbia, Aliso Viejo, CA, 92656

Company Facts

4,610 Employees
IPO DateJul 30, 2021
CountryUS
Actively Trading

Frequently Asked Questions